Natriumchloride Noridem (Sodium Chloride)

Sodium chloride, the active ingredient in Natriumchloride Noridem, is an electrolyte solution presented as an injection solution for intravenous use. It is employed to restore extracellular fluid volume and correct electrolyte imbalances in patients requiring rapid fluid replacement. GNH USA supplies Natriumchloride Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Natriumchloride Noridem is an intravenous electrolyte solution used in conditions that involve fluid loss or electrolyte disturbance. - Fluid replacement: rehydrates patients with acute volume depletion. - Electrolyte imbalance correction: restores normal sodium and chloride concentrations. - Hypovolemia: expands intravascular volume to maintain blood pressure. - Hyponatremia: raises serum sodium levels toward normal range.

Adverse reactions may occur with any intravenous therapy.

Common Side Effects: - Injection site pain: mild discomfort at the infusion site. - Mild hypernatremia: transient elevation of serum sodium. - Fluid overload: mild peripheral edema.

Serious or Rare Side Effects: - Severe hypernatremia: rapid rise in sodium causing neurologic symptoms. - Pulmonary edema: accumulation of fluid in the lungs. - Anaphylactic reaction: severe allergic response requiring immediate medical intervention.

Use Natriumchloride Noridem with clinical vigilance to avoid complications. - Assess fluid status: evaluate patient’s volume needs before administration. - Monitor serum electrolytes: check sodium and chloride levels regularly. - Caution in renal impairment: adjust volume to prevent overload. - Avoid rapid infusion in cardiac failure: infuse at recommended rates. - Adjust dose in pediatric patients: follow weight‑based guidelines. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Natriumchloride Noridem may interact with other agents that affect fluid or electrolyte balance.

Major Interactions (Avoid): - Concurrent hypertonic saline solutions: risk of severe hypernatremia. - Co‑administration with potassium chloride solutions: may cause dangerous electrolyte shifts.

Moderate Interactions (Monitor Closely): - Loop diuretics: increase sodium loss, requiring closer monitoring. - ACE inhibitors: potential for altered potassium levels when combined with potassium‑containing fluids. - NSAIDs: may impair renal function, enhancing risk of fluid overload.